Aktis Oncology, Inc.
Clinical trials sponsored by Aktis Oncology, Inc., explained in plain language.
-
Radioactive 'Smart Bomb' targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase trial is testing a new radioactive drug that seeks out a protein called Nectin-4 found on many cancer cells. The drug delivers a dose of radiation directly to the tumor, aiming to destroy it while sparing healthy tissue. About 150 adults with advanced bladder, br…
Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
New radioactive drug targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-stage study tests a new radioactive drug (B7-H3 radiopharmaceutical) in people with metastatic castration-resistant prostate cancer that has stopped responding to standard hormone therapy. The drug is designed to deliver radiation directly to cancer cells. The main goa…
Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated Jun 22, 2026 11:54 UTC